Effectiveness of drug combinations for urethral discharge and pelvic inflammatory disease in records of STI clients by syndrome among intervention (D1, D2) and reference (D3) GPs (n = 1105)
| District | STI syndrome | Time period (n) | Syndrome effectiveness | p Value | ||
|---|---|---|---|---|---|---|
| Effective | Partially effective | Ineffective | ||||
| D1 | Urethral discharge | Before (64) | 18 (28.1%) | 31 (48.4%) | 15 (23.4%) | 0.595 |
| After (56) | 18 (32.1%) | 29 (51.8%) | 9 (16.1%) | |||
| PID | Before (129) | 26 (20.2%) | 89 (69.0%) | 14 (10.9%) | 0.184 | |
| After (143) | 30 (21.0%) | 106 (74.1%) | 7 (4.9%) | |||
| D2 | Urethral discharge | Before (78) | 23 (29.5%) | 42 (53.8%) | 13 (16.7%) | 0.005 |
| After (56) | 30 (53.6%) | 24 (42.9%) | 2 (3.6%) | |||
| PID | Before (143) | 24 (16.8%) | 110 (76.9%) | 9 (6.3%) | 0.699 | |
| After (163) | 32 (19.6%) | 118 (72.4%) | 13 (8.0%) | |||
| D3 | Urethral discharge | Before (33) | 6 (18.2%) | 18 (54.5%) | 9 (27.3%) | 0.036 |
| After (31) | 15 (48.4%) | 11 (35.5%) | 5 (16.1%) | |||
| PID | Before (103) | 14 (13.6%) | 69 (67.0%) | 20 (19.4%) | 0.007 | |
| After (106) | 24 (22.6%) | 48 (45.3%) | 34 (32.1%) | |||